Nontuberculous mycobacterial (NTM) pulmonary disease is a chronic respiratory infection associated with declining lung function, radiological deterioration and significantly increased morbidity and mortality. Patients often have underlying lung conditions, particularly bronchiectasis and COPD. NTM pulmonary disease is difficult to treat because mycobacteria can evade host defences and antimicrobial therapy through extracellular persistence in biofilms and sequestration into macrophages. Management of NTM pulmonary disease remains challenging and outcomes are often poor, partly due to limited penetration of antibiotics into intracellular spaces and biofilms. Efficient drug delivery to the site of infection is therefore a key objective of tre...
Non-tuberculous mycobacterial (NTM) infections are increasingly rapidly worldwide. The reason for th...
Treatment of pulmonary tuberculosis is a challenging problem worldwide due to the high toxicity of c...
This is a critical review on research conducted in the field of pulmonary delivery of liposomes. Iss...
Nontuberculous mycobacterial (NTM) pulmonary disease is a chronic respiratory infection associated w...
Pulmonary infections caused by nontuberculous mycobacteria (NTM) are an increasing problem in indivi...
The management of difficult-to-treat acute and chronic respiratory infections (infections in cystic ...
Liposomes are established drug carriers for inhalation owing to their biocompatibility, biodegradabi...
Nontuberculous mycobacterial infections rapidly emerge and demand potent medications to cope with re...
Pulmonary infections may be fatal especially in immunocompromised patients and patients with underly...
IntroductionThe prevalence of Mycobacterium avium complex (MAC) is increasing globally. Macrolide-ba...
Background: Mycobacterium tuberculosis (M. TB) remains the prime cause of bacterial mortality and mo...
Non-tuberculous mycobacterial (NTM) infections are increasingly rapidly worldwide. The reason for th...
Treatment of pulmonary tuberculosis is a challenging problem worldwide due to the high toxicity of c...
This is a critical review on research conducted in the field of pulmonary delivery of liposomes. Iss...
Nontuberculous mycobacterial (NTM) pulmonary disease is a chronic respiratory infection associated w...
Pulmonary infections caused by nontuberculous mycobacteria (NTM) are an increasing problem in indivi...
The management of difficult-to-treat acute and chronic respiratory infections (infections in cystic ...
Liposomes are established drug carriers for inhalation owing to their biocompatibility, biodegradabi...
Nontuberculous mycobacterial infections rapidly emerge and demand potent medications to cope with re...
Pulmonary infections may be fatal especially in immunocompromised patients and patients with underly...
IntroductionThe prevalence of Mycobacterium avium complex (MAC) is increasing globally. Macrolide-ba...
Background: Mycobacterium tuberculosis (M. TB) remains the prime cause of bacterial mortality and mo...
Non-tuberculous mycobacterial (NTM) infections are increasingly rapidly worldwide. The reason for th...
Treatment of pulmonary tuberculosis is a challenging problem worldwide due to the high toxicity of c...
This is a critical review on research conducted in the field of pulmonary delivery of liposomes. Iss...